Contents:

1 TOC 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 What Is This Report About? 3 Definitions of the Markets Covered in the Report 3.1 In Vitro Diagnostics 3.2 Clinical Chemistry 3.3 Genetic Testing 3.4 Haematology 3.5 Histology And Cytology 3.6 Immuno Chemistry 3.7 Infectious Immunology 3.8 Microbiology Culture 4 In Vitro Diagnostics in Europe 4.1 In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015 4.2 In Vitro Diagnostics, Europe, Company share (2007-2008) 5 In Vitro Diagnostics In Germany 5.1 In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015 5.2 In Vitro Diagnostics, Germany, Distribution Share (2007-2008) 5.2.1 Clinical Chemistry Distribution Share (2007-2008) 5.2.2 Genetic Testing Distribution Share (2007-2008) 5.2.3 Haematology Distribution Share (2007-2008) 5.2.4 Histology And Cytology Distribution Share (2007-2008) 5.2.5 Immuno Chemistry Distribution Share (2007-2008) 5.2.6 Infectious Immunology Distribution Share (2007-2008) 5.2.7 Microbiology Culture Distribution Share (2007-2008) 5.3 In Vitro Diagnostics, Germany, Company Share (2007-2008) 5.3.1 In Vitro Diagnostics, Germany, Company Share (2007-2008) 5.3.2 Clinical Chemistry, Germany, Company Share (2007-2008) 5.3.3 Genetic Testing, Germany, Company Share (2007-2008) 5.3.4 Haematology, Germany, Company Share (2007-2008) 5.3.5 Histology And Cytology, Germany, Company Share (2007-2008) 5.3.6 Immuno Chemistry, Germany, Company Share (2007-2008) 5.3.7 Infectious Immunology, Germany, Company Share (2007-2008) 5.3.8 Microbiology Culture, Germany, Company Share (2007-2008) 6 In Vitro Diagnostics In France 6.1 In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015 6.2 In Vitro Diagnostics, France, Distribution Share (2007-2008) 6.2.1 Clinical Chemistry Distribution Share (2007-2008) 6.2.2 Genetic Testing Distribution Share (2007-2008) 6.2.3 Haematology Distribution Share (2007-2008) 6.2.4 Histology And Cytology Distribution Share (2007-2008) 6.2.5 Immuno Chemistry Distribution Share (2007-2008) 6.2.6 Infectious Immunology Distribution Share (2007-2008) 6.2.7 Microbiology Culture Distribution Share (2007-2008) 6.3 In Vitro Diagnostics, France, Company Share (2007-2008) 6.3.1 In Vitro Diagnostics, France, Company Share (2007-2008) 6.3.2 Clinical Chemistry, France, Company Share (2007-2008) 6.3.3 Genetic Testing, France, Company Share (2007-2008) 6.3.4 Haematology, France, Company Share (2007-2008) 6.3.5 Histology And Cytology, France, Company Share (2007-2008) 6.3.6 Immuno Chemistry, France, Company Share (2007-2008) 6.3.7 Infectious Immunology, France, Company Share (2007-2008) 6.3.8 Microbiology Culture, France, Company Share (2007-2008) 7 In Vitro Diagnostics In United Kingdom 7.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015 7.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2007-2008) 7.2.1 Clinical Chemistry Distribution Share (2007-2008) 7.2.2 Genetic Testing Distribution Share (2007-2008) 7.2.3 Haematology Distribution Share (2007-2008) 7.2.4 Histology And Cytology Distribution Share (2007-2008) 7.2.5 Immuno Chemistry Distribution Share (2007-2008) 7.2.6 Infectious Immunology Distribution Share (2007-2008) 7.2.7 Microbiology Culture Distribution Share (2007-2008) 7.3 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008) 7.3.1 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008) 7.3.2 Clinical Chemistry, United Kingdom, Company Share (2007-2008) 7.3.3 Genetic Testing, United Kingdom, Company Share (2007-2008) 7.3.4 Haematology, United Kingdom, Company Share (2007-2008) 7.3.5 Histology And Cytology, United Kingdom, Company Share (2007-2008) 7.3.6 Immuno Chemistry, United Kingdom, Company Share (2007-2008) 7.3.7 Infectious Immunology, United Kingdom, Company Share (2007-2008) 7.3.8 Microbiology Culture, United Kingdom, Company Share (2007-2008) 8 In Vitro Diagnostics In Italy 8.1 In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015 8.2 In Vitro Diagnostics, Italy, Distribution Share (2007-2008) 8.2.1 Clinical Chemistry Distribution Share (2007-2008) 8.2.2 Genetic Testing Distribution Share (2007-2008) 8.2.3 Haematology Distribution Share (2007-2008) 8.2.4 Histology And Cytology Distribution Share (2007-2008) 8.2.5 Immuno Chemistry Distribution Share (2007-2008) 8.2.6 Infectious Immunology Distribution Share (2007-2008) 8.2.7 Microbiology Culture Distribution Share (2007-2008) 8.3 In Vitro Diagnostics, Italy, Company Share (2007-2008) 8.3.1 In Vitro Diagnostics, Italy, Company Share (2007-2008) 8.3.2 Clinical Chemistry, Italy, Company Share (2007-2008) 8.3.3 Genetic Testing, Italy, Company Share (2007-2008) 8.3.4 Haematology, Italy, Company Share (2007-2008) 8.3.5 Histology And Cytology, Italy, Company Share (2007-2008) 8.3.6 Immuno Chemistry, Italy, Company Share (2007-2008) 8.3.7 Infectious Immunology, Italy, Company Share (2007-2008) 8.3.8 Microbiology Culture, Italy, Company Share (2007-2008) 9 In Vitro Diagnostics In Spain 9.1 In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015 9.2 In Vitro Diagnostics, Spain, Distribution Share (2007-2008) 9.2.1 Clinical Chemistry Distribution Share (2007-2008) 9.2.2 Genetic Testing Distribution Share (2007-2008) 9.2.3 Haematology Distribution Share (2007-2008) 9.2.4 Histology And Cytology Distribution Share (2007-2008) 9.2.5 Immuno Chemistry Distribution Share (2007-2008) 9.2.6 Infectious Immunology Distribution Share (2007-2008) 9.2.7 Microbiology Culture Distribution Share (2007-2008) 9.3 In Vitro Diagnostics, Spain, Company Share (2007-2008) 9.3.1 In Vitro Diagnostics, Spain, Company Share (2007-2008) 9.3.2 Clinical Chemistry, Spain, Company Share (2007-2008) 9.3.3 Genetic Testing, Spain, Company Share (2007-2008) 9.3.4 Haematology, Spain, Company Share (2007-2008) 9.3.5 Histology And Cytology, Spain, Company Share (2007-2008) 9.3.6 Immuno Chemistry, Spain, Company Share (2007-2008) 9.3.7 Infectious Immunology, Spain, Company Share (2007-2008) 9.3.8 Microbiology Culture, Spain, Company Share (2007-2008) 10 In Vitro Diagnostics In Netherlands 10.1 In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), 2000-2015 10.2 In Vitro Diagnostics, Netherlands, Distribution Share (2007-2008) 10.2.1 Clinical Chemistry Distribution Share (2007-2008) 10.2.2 Genetic Testing Distribution Share (2007-2008) 10.2.3 Haematology Distribution Share (2007-2008) 10.2.4 Histology And Cytology Distribution Share (2007-2008) 10.2.5 Immuno Chemistry Distribution Share (2007-2008) 10.2.6 Infectious Immunology Distribution Share (2007-2008) 10.2.7 Microbiology Culture Distribution Share (2007-2008) 10.3 In Vitro Diagnostics, Netherlands, Company Share (2007-2008) 10.3.1 In Vitro Diagnostics, Netherlands, Company Share (2007-2008) 10.3.2 Clinical Chemistry, Netherlands, Company Share (2007-2008) 10.3.3 Genetic Testing, Netherlands, Company Share (2007-2008) 10.3.4 Haematology, Netherlands, Company Share (2007-2008) 10.3.5 Histology And Cytology, Netherlands, Company Share (2007-2008) 10.3.6 Immuno Chemistry, Netherlands, Company Share (2007-2008) 10.3.7 Infectious Immunology, Netherlands, Company Share (2007-2008) 10.3.8 Microbiology Culture, Netherlands, Company Share (2007-2008) 11 In Vitro Diagnostics In Belgium 11.1 In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015 11.2 In Vitro Diagnostics, Belgium, Distribution Share (2007-2008) 11.2.1 Clinical Chemistry Distribution Share (2007-2008) 11.2.2 Genetic Testing Distribution Share (2007-2008) 11.2.3 Haematology Distribution Share (2007-2008) 11.2.4 Histology And Cytology Distribution Share (2007-2008) 11.2.5 Immuno Chemistry Distribution Share (2007-2008) 11.2.6 Infectious Immunology Distribution Share (2007-2008) 11.2.7 Microbiology Culture Distribution Share (2007-2008) 11.3 In Vitro Diagnostics, Belgium, Company Share (2007-2008) 11.3.1 In Vitro Diagnostics, Belgium, Company Share (2007-2008) 11.3.2 Clinical Chemistry, Belgium, Company Share (2007-2008) 11.3.3 Genetic Testing, Belgium, Company Share (2007-2008) 11.3.4 Haematology, Belgium, Company Share (2007-2008) 11.3.5 Histology And Cytology, Belgium, Company Share (2007-2008) 11.3.6 Immuno Chemistry, Belgium, Company Share (2007-2008) 11.3.7 Infectious Immunology, Belgium, Company Share (2007-2008) 11.3.8 Microbiology Culture, Belgium, Company Share (2007-2008) 12 Overview of Key Companies in Europe In Vitro Diagnostics Market 12.1 Ventana Medical Systems, Inc 12.1.1 Company Overview 12.2 Sysmex Corporation 12.2.1 Company Overview 12.2.2 Sysmex Corporation Pipeline Products 12.3 Siemens Healthcare 12.3.1 Company Overview 12.4 Qiagen N.V 12.4.1 Company Overview 12.4.2 Qiagen N.V. Pipeline Products 12.5 Phadia AB 12.5.1 Company Overview 12.5.2 Phadia AB Pipeline Products 12.6 Ortho-Clinical Diagnostics Inc 12.6.1 Company Overview 12.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products 12.7 Mindray Medical International Limited 12.7.1 Company Overview 12.7.2 Mindray Medical International Limited Pipeline Products 12.8 Inverness Medical Innovations, Inc 12.8.1 Company Overview 12.8.2 Inverness Medical Innovations, Inc. Pipeline Products 12.9 Hologic, Inc 12.9.1 Company Overview 12.9.2 Hologic, Inc. Pipeline Products 12.10 Gen-Probe Incorporated 12.10.1 Company Overview 12.10.2 Gen-Probe Incorporated Pipeline Products 12.11 F. Hoffmann-La Roche Ltd 12.11.1 Company Overview 12.12 Digene Corporation 12.12.1 Company Overview 12.13 Dade Behring Holdings, Inc 12.13.1 Company Overview 12.14 DiaSorin S.p.A 12.14.1 Company Overview 12.14.2 DiaSorin S.p.A Pipeline Products 12.15 Bio-Rad Laboratories, Inc 12.15.1 Company Overview 12.16 bioMerieux S.A 12.16.1 Company Overview 12.16.2 Biomerieux Sa Pipeline Products 12.17 Becton, Dickinson and Company 12.17.1 Company Overview 12.17.2 Becton, Dickinson and Company Pipeline Products 12.18 Beckman Coulter, Inc 12.18.1 Company Overview 12.18.2 Beckman Coulter, Inc. Pipeline Products 12.19 Abbott Laboratories 12.19.1 Company Overview 12.19.2 Abbott Laboratories Pipeline Products 13 Financial Deals Landscape 13.1 Acquisition 13.1.1 Lab21 Acquires Delphic Diagnostic From BDO 13.1.2 International SOS Acquires Majority Stake In Abermed 13.1.3 Bio-Rad Laboratories To Acquire Medical Diagnostics Segment From Biotest 13.1.4 ERBA DIAGNOSTICS MANNHEIM Acquires PLIVA-Lachema Diagnostika 13.1.5 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S 13.1.6 QIAGEN Completes Acquisition Of DxS 13.2 Private Equity 13.2.1 Legal & General Ventures To Sell LGC 13.2.2 LinkMed To Acquire 51% Stake In AbSorber From Koncentra And Jan Holgersson 13.2.3 North Atlantic Value Completes Acquisition Of Celsis International 13.2.4 The Riverside Acquires Crioestaminal Saude e Tecnologia 13.3 Venture Financing 13.3.1 Curetis Secures $27.89 Million In Series A Round Of Financing 13.3.2 Biomedical Diagnostics Secures $4.52 Million In Financing 13.3.3 Pronota Secures Additional $1.92 Million In Series B Round Of Financing 13.3.4 Biocartis Secures $14.9 Million In Series A Equity Round Of Financing 13.3.5 mtm laboratories Secures $10.21 Million In Fourth Tranche Of Series C Financing Round 13.3.6 Kreatech Diagnostics Secures $2.86 Million In Financing Round 13.3.7 Agendia Raises $23 Million In Series E Financing 13.4 Equity Offerings 13.4.1 ExonHit Therapeutics Plans Rights Issue Of New Shares For $25.67 Million 13.4.2 Osmetech Announces Private Placement Of Shares For $16.3 Million 13.4.3 Mediwatch Completes Private Placement Of $0.57 Million 13.4.4 QIAGEN Completes Private Placement Of Its Common Stock For $640 Million 13.5 Partnerships 13.5.1 HairDX Enters Into Distribution Agreement With Svenson Haar Studios 13.5.2 MabCure Signs Research Agreement With AZ Sint-Lucas 14 APPENDIX 14.1 Global Markets Direct Research Methodology 14.2 Secondary Research 14.3 Primary Research 14.4 Models 14.5 Forecasts 14.6 Expert Panel Validation 14.7 Currency Conversion 14.8 Contact Us 14.9 Disclaimer 1.1 List of Tables Table 1: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015 Table 2: Europe In Vitro Diagnostics Market, Cross-Category Analysis, 2000-2015 Table 3: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Historic, 2000-2008 Table 4: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Forecast, 2008-2015 Table 5: In Vitro Diagnostics, Europe, Company share by Revenue ($ mn), 2007-2008 Table 6: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015 Table 7: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, 2000-2008 Table 8: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Forecast, 2008-2015 Table 9: Clinical Chemistry, Germany, Distribution Share by Revenue ($mn), 2007-2008 Table 10: Genetic Testing, Germany, Distribution Share by Revenue ($mn), 2007-2008 Table 11: Haematology, Germany, Distribution Share by Revenue ($mn), 2007-2008 Table 12: Histology And Cytology, Germany, Distribution Share by Revenue ($mn), 2007-2008 Table 13: Immuno Chemistry, Germany, Distribution Share by Revenue ($mn), 2007-2008 Table 14: Infectious Immunology, Germany, Distribution Share by Revenue ($mn), 2007-2008 Table 15: Microbiology Culture, Germany, Distribution Share by Revenue ($mn), 2007-2008 Table 16: In Vitro Diagnostics, Germany, Company Share by Revenue ($ mn), 2007-2008 Table 17: Clinical Chemistry, Germany, Company Share by Revenue ($ mn), 2007-2008 Table 18: Genetic Testing, Germany, Company Share by Revenue ($ mn), 2007-2008 Table 19: Haematology, Germany, Company Share by Revenue ($ mn), 2007-2008 Table 20: Histology And Cytology, Germany, Company Share by Revenue ($ mn), 2007-2008 Table 21: Immuno Chemistry, Germany, Company Share by Revenue ($ mn), 2007-2008 Table 22: Infectious Immunology, Germany, Company Share by Revenue ($ mn), 2007-2008 Table 23: Microbiology Culture, Germany, Company Share by Revenue ($ mn), 2007-2008 Table 24: In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015 Table 25: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, 2000-2008 Table 26: In Vitro Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015 Table 27: Clinical Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008 Table 28: Genetic Testing, France, Distribution Share by Revenue ($mn), 2007-2008 Table 29: Haematology, France, Distribution Share by Revenue ($mn), 2007-2008 Table 30: Histology And Cytology, France, Distribution Share by Revenue ($mn), 2007-2008 Table 31: Immuno Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008 Table 32: Infectious Immunology, France, Distribution Share by Revenue ($mn), 2007-2008 Table 33: Microbiology Culture, France, Distribution Share by Revenue ($mn), 2007-2008 Table 34: In Vitro Diagnostics, France, Company Share by Revenue ($ mn), 2007-2008 Table 35: Clinical Chemistry, France, Company Share by Revenue ($ mn), 2007-2008 Table 36: Genetic Testing, France, Company Share by Revenue ($ mn), 2007-2008 Table 37: Haematology, France, Company Share by Revenue ($ mn), 2007-2008 Table 38: Histology And Cytology, France, Company Share by Revenue ($ mn), 2007-2008 Table 39: Immuno Chemistry, France, Company Share by Revenue ($ mn), 2007-2008 Table 40: Infectious Immunology, France, Company Share by Revenue ($ mn), 2007-2008 Table 41: Microbiology Culture, France, Company Share by Revenue ($ mn), 2007-2008 Table 42: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015 Table 43: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008 Table 44: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015 Table 45: Clinical Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 Table 46: Genetic Testing, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 Table 47: Haematology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 Table 48: Histology And Cytology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 Table 49: Immuno Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 Table 50: Infectious Immunology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 Table 51: Microbiology Culture, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 Table 52: In Vitro Diagnostics, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 Table 53: Clinical Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 Table 54: Genetic Testing, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 Table 55: Haematology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 Table 56: Histology And Cytology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 Table 57: Immuno Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 Table 58: Infectious Immunology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 Table 59: Microbiology Culture, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 Table 60: In Vqitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015 Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008 Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015 Table 63: Clinical Chemistry, Italy, Distribution Share by Revenue ($mn), 2007-2008 Table 64: Genetic Testing, Italy, Distribution Share by Revenue ($mn), 2007-2008 Table 65: Haematology, Italy, Distribution Share by Revenue ($mn), 2007-2008 Table 66: Histology And Cytology, Italy, Distribution Share by Revenue ($mn), 2007-2008 Table 67: Immuno Chemistry, Italy, Distribution Share by Revenue ($mn), 2007-2008 Table 68: Infectious Immunology, Italy, Distribution Share by Revenue ($mn), 2007-2008 Table 69: Microbiology Culture, Italy, Distribution Share by Revenue ($mn), 2007-2008 Table 70: In Vitro Diagnostics, Italy, Company Share by Revenue ($ mn), 2007-2008 Table 71: Clinical Chemistry, Italy, Company Share by Revenue ($ mn), 2007-2008 Table 72: Genetic Testing, Italy, Company Share by Revenue ($ mn), 2007-2008 Table 73: Haematology, Italy, Company Share by Revenue ($ mn), 2007-2008 Table 74: Histology And Cytology, Italy, Company Share by Revenue ($ mn), 2007-2008 Table 75: Immuno Chemistry, Italy, Company Share by Revenue ($ mn), 2007-2008 Table 76: Infectious Immunology, Italy, Company Share by Revenue ($ mn), 2007-2008 Table 77: Microbiology Culture, Italy, Company Share by Revenue ($ mn), 2007-2008 Table 78: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015 Table 79: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008 Table 80: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015 Table 81: Clinical Chemistry, Spain, Distribution Share by Revenue ($mn), 2007-2008 Table 82: Genetic Testing, Spain, Distribution Share by Revenue ($mn), 2007-2008 Table 83: Haematology, Spain, Distribution Share by Revenue ($mn), 2007-2008 Table 84: Histology And Cytology, Spain, Distribution Share by Revenue ($mn), 2007-2008 Table 85: Immuno Chemistry, Spain, Distribution Share by Revenue ($mn), 2007-2008 Table 86: Infectious Immunology, Spain, Distribution Share by Revenue ($mn), 2007-2008 Table 87: Microbiology Culture, Spain, Distribution Share by Revenue ($mn), 2007-2008 Table 88: In Vitro Diagnostics, Spain, Company Share by Revenue ($ mn), 2007-2008 Table 89: Clinical Chemistry, Spain, Company Share by Revenue ($ mn), 2007-2008 Table 90: Genetic Testing, Spain, Company Share by Revenue ($ mn), 2007-2008 Table 91: Haematology, Spain, Company Share by Revenue ($ mn), 2007-2008 Table 92: Histology And Cytology, Spain, Company Share by Revenue ($ mn), 2007-2008 Table 93: Immuno Chemistry, Spain, Company Share by Revenue ($ mn), 2007-2008 Table 94: Infectiozus Immunology, Spain, Company Share by Revenue ($ mn), 2007-2008 Table 95: Microbiology Culture, Spain, Company Share by Revenue ($ mn), 2007-2008 Table 96: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), 2000-2015 Table 97: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008 Table 98: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015 Table 99: Clinical Chemistry, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 Table 100: Genetic Testing, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 Table 101: Haematology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 Table 102: Histology And Cytology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 Table 103: Immuno Chemistry, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 Table 104: Infectious Immunology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 Table 105: Microbiology Culture, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 Table 106: In Vitro Diagnostics, Netherlands, Company Share by Revenue ($ mn), 2007-2008 Table 107: Clinical Chemistry, Netherlands, Company Share by Revenue ($ mn), 2007-2008 Table 108: Genetic Testing, Netherlands, Company Share by Revenue ($ mn), 2007-2008 Table 109: Haematology, Netherlands, Company Share by Revenue ($ mn), 2007-2008 Table 110: Histology And Cytology, Netherlands, Company Share by Revenue ($ mn), 2007-2008 Table 111: Immuno Chemistry, Netherlands, Company Share by Revenue ($ mn), 2007-2008 Table 112: Infectious Immunology, Netherlands, Company Share by Revenue ($ mn), 2007-2008 Table 113: Microbiology Culture, Netherlands, Company Share by Revenue ($ mn), 2007-2008 Table 114: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015 Table 115: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Historic, 2000-2008 Table 116: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015 Table 117: Clinical Chemistry, Belgium, Distribution Share by Revenue ($mn), 2007-2008 Table 118: Genetic Testing, Belgium, Distribution Share by Revenue ($mn), 2007-2008 Table 119: Haematology, Belgium, Distribution Share by Revenue ($mn), 2007-2008 Table 120: Histology And Cytology, Belgium, Distribution Share by Revenue ($mn), 2007-2008 Table 121: Immuno Chemistry, Belgium, Distribution Share by Revenue ($mn), 2007-2008 Table 122: Infectious Immunology, Belgium, Distribution Share by Revenue ($mn), 2007-2008 Table 123: Microbiology Culture, Belgium, Distribution Share by Revenue ($mn), 2007-2008 Table 124: In Vitro Diagnostics, Belgium, Company Share by Revenue ($ mn), 2007-2008 Table 125: Clinical Chemistry, Belgium, Company Share by Revenue ($ mn), 2007-2008 Table 126: Genetic Testing, Belgium, Company Share by Revenue ($ mn), 2007-2008 Table 127: Haematology, Belgium, Company Share by Revenue ($ mn), 2007-2008 Table 128: Histology And Cytology, Belgium, Company Share by Revenue ($ mn), 2007-2008 Table 129: Immuno Chemistry, Belgium, Company Share by Revenue ($ mn), 2007-2008 Table 130: Infectious Immunology, Belgium, Company Share by Revenue ($ mn), 2007-2008 Table 131: Microbiology Culture, Belgium, Company Share by Revenue ($ mn), 2007-2008 Table 132: Sysmex Corporation Pipeline Products by Equipment Type Table 133: Sysmex Corporation Pipeline Products By Development Stage Table 134: Sysmex Corporation Pipeline Products By Therapy Area Table 135: Qiagen N.V. Pipeline Products by Equipment Type Table 136: Qiagen N.V. Pipeline Products By Development Stage Table 137: Qiagen N.V. Pipeline Products By Therapy Area Table 138: Phadia AB Pipeline Products by Equipment Type Table 139: Phadia AB Pipeline Products By Development Stage Table 140: Phadia AB Pipeline Products By Therapy Area Table 141: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type Table 142: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage Table 143: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area Table 144: Ortho-Clinical Diagnostics Inc. Pipeline Products By Clinical Trials Table 145: Mindray Medical International Limited Pipeline Products by Equipment Type Table 146: Mindray Medical International Limited Pipeline Products By Development Stage Table 147: Mindray Medical International Limited Pipeline Products By Therapy Area Table 148: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type Table 149: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage Table 150: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area Table 151: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials Table 152: Hologic, Inc. Pipeline Products by Equipment Type Table 153: Hologic, Inc. Pipeline Products By Development Stage Table 154: Hologic, Inc. Pipeline Products By Therapy Area Table 155: Gen-Probe Incorporated Pipeline Products by Equipment Type Table 156: Gen-Probe Incorporated Pipeline Products By Development Stage Table 157: Gen-Probe Incorporated Pipeline Products By Therapy Area Table 158: Gen-Probe Incorporated Pipeline Products By Clinical Trials Table 159: DiaSorin S.p.A Pipeline Products by Equipment Type Table 160: DiaSorin S.p.A Pipeline Products By Development Stage Table 161: DiaSorin S.p.A Pipeline Products By Therapy Area Table 162: Biomerieux Sa Pipeline Products by Equipment Type Table 163: Biomerieux Sa Pipeline Products By Development Stage Table 164: Biomerieux Sa Pipeline Products By Therapy Area Table 165: Biomerieux Sa Pipeline Products By Clinical Trials Table 166: Becton, Dickinson and Company Pipeline Products by Equipment Type Table 167: Becton, Dickinson and Company Pipeline Products By Development Stage Table 168: Becton, Dickinson and Company Pipeline Products By Therapy Area Table 169: Beckman Coulter, Inc. Pipeline Products by Equipment Type Table 170: Beckman Coulter, Inc. Pipeline Products By Development Stage Table 171: Beckman Coulter, Inc. Pipeline Products By Therapy Area Table 172: Abbott Laboratories Pipeline Products by Equipment Type Table 173: Abbott Laboratories Pipeline Products By Development Stage Table 174: Abbott Laboratories Pipeline Products By Therapy Area Table 175: Lab21 Acquires Delphic Diagnostic From BDO Table 176: International SOS Acquires Majority Stake In Abermed Table 177: Bio-Rad Laboratories To Acquire Medical Diagnostics Segment From Biotest Table 178: ERBA DIAGNOSTICS MANNHEIM Acquires PLIVA-Lachema Diagnostika Table 179: Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S Table 180: QIAGEN Completes Acquisition Of DxS Table 181: Legal & General Ventures To Sell LGC Table 182: LinkMed To Acquire 51% Stake In AbSorber From Koncentra And Jan Holgersson Table 183: North Atlantic Value Completes Acquisition Of Celsis International Table 184: The Riverside Acquires Crioestaminal Saude e Tecnologia Table 185: Curetis Secures $27.89 Million In Series A Round Of Financing Table 186: Biomedical Diagnostics Secures $4.52 Million In Financing Table 187: Pronota Secures Additional $1.92 Million In Series B Round Of Financing Table 188: Biocartis Secures $14.9 Million In Series A Equity Round Of Financing Table 189: mtm laboratories Secures $10.21 Million In Fourth Tranche Of Series C Financing Round Table 190: Kreatech Diagnostics Secures $2.86 Million In Financing Round Table 191: Agendia Raises $23 Million In Series E Financing Table 192: ExonHit Therapeutics Plans Rights Issue Of New Shares For $25.67 Million Table 193: Osmetech Announces Private Placement Of Shares For $16.3 Million Table 194: Mediwatch Completes Private Placement Of $0.57 Million Table 195: QIAGEN Completes Private Placement Of Its Common Stock For $640 Million Table 196: HairDX Enters Into Distribution Agreement With Svenson Haar Studios Table 197: MabCure Signs Research Agreement With AZ Sint-Lucas Table 198: USD to Local Currency, Average Exchange Rate 2008 1.2 List of Figures Figure 1: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015 Figure 2: Europe In Vitro Diagnostics Market, Cross-Category Analysis, 2000-2015 Figure 3: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Historic, 2000-2008 Figure 4: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 5: In Vitro Diagnostics, Europe, Company share (%), 2008 Figure 6: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015 Figure 7: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, 2000-2008 Figure 8: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 9: In Vitro Diagnostics, Germany, Company Share (%), 2008 Figure 10: Clinical Chemistry, Germany, Company Share (%), 2008 Figure 11: Genetic Testing, Germany, Company Share (%), 2008 Figure 12: Haematology, Germany, Company Share (%), 2008 Figure 13: Histology And Cytology, Germany, Company Share (%), 2008 Figure 14: Immuno Chemistry, Germany, Company Share (%), 2008 Figure 15: Infectious Immunology, Germany, Company Share (%), 2008 Figure 16: Microbiology Culture, Germany, Company Share (%), 2008 Figure 17: In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015 Figure 18: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, 2000-2008 Figure 19: In Vitro Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 20: In Vitro Diagnostics, France, Company Share (%), 2008 Figure 21: Clinical Chemistry, France, Company Share (%), 2008 Figure 22: Genetic Testing, France, Company Share (%), 2008 Figure 23: Haematology, France, Company Share (%), 2008 Figure 24: Histology And Cytology, France, Company Share (%), 2008 Figure 25: Immuno Chemistry, France, Company Share (%), 2008 Figure 26: Infectious Immunology, France, Company Share (%), 2008 Figure 27: Microbiology Culture, France, Company Share (%), 2008 Figure 28: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015 Figure 29: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008 Figure 30: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 31: In Vitro Diagnostics, United Kingdom, Company Share (%), 2008 Figure 32: Clinical Chemistry, United Kingdom, Company Share (%), 2008 Figure 33: Genetic Testing, United Kingdom, Company Share (%), 2008 Figure 34: Haematology, United Kingdom, Company Share (%), 2008 Figure 35: Histology And Cytology, United Kingdom, Company Share (%), 2008 Figure 36: Immuno Chemistry, United Kingdom, Company Share (%), 2008 Figure 37: Infectious Immunology, United Kingdom, Company Share (%), 2008 Figure 38: Microbiology Culture, United Kingdom, Company Share (%), 2008 Figure 39: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015 Figure 40: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008 Figure 41: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 42: In Vitro Diagnostics, Italy, Company Share (%), 2008 Figure 43: Clinical Chemistry, Italy, Company Share (%), 2008 Figure 44: Genetic Testing, Italy, Company Share (%), 2008 Figure 45: Haematology, Italy, Company Share (%), 2008 Figure 46: Histology And Cytology, Italy, Company Share (%), 2008 Figure 47: Immuno Chemistry, Italy, Company Share (%), 2008 Figure 48: Infectious Immunology, Italy, Company Share (%), 2008 Figure 49: Microbiology Culture, Italy, Company Share (%), 2008 Figure 50: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015 Figure 51: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008 Figure 52: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 53: In Vitro Diagnostics, Spain, Company Share (%), 2008 Figure 54: Clinical Chemistry, Spain, Company Share (%), 2008 Figure 55: Genetic Testing, Spain, Company Share (%), 2008 Figure 56: Haematology, Spain, Company Share (%), 2008 Figure 57: Histology And Cytology, Spain, Company Share (%), 2008 Figure 58: Immuno Chemistry, Spain, Company Share (%), 2008 Figure 59: Infectious Immunology, Spain, Company Share (%), 2008 Figure 60: Microbiology Culture, Spain, Company Share (%), 2008 Figure 61: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), 2000-2015 Figure 62: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008 Figure 63: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 64: In Vitro Diagnostics, Netherlands, Company Share (%), 2008 Figure 65: Clinical Chemistry, Netherlands, Company Share (%), 2008 Figure 66: Genetic Testing, Netherlands, Company Share (%), 2008 Figure 67: Haematology, Netherlands, Company Share (%), 2008 Figure 68: Histology And Cytology, Netherlands, Company Share (%), 2008 Figure 69: Immuno Chemistry, Netherlands, Company Share (%), 2008 Figure 70: Infectious Immunology, Netherlands, Company Share (%), 2008 Figure 71: Microbiology Culture, Netherlands, Company Share (%), 2008 Figure 72: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015 Figure 73: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Historic, 2000-2008 Figure 74: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 75: In Vitro Diagnostics, Belgium, Company Share (%), 2008 Figure 76: Clinical Chemistry, Belgium, Company Share (%), 2008 Figure 77: Genetic Testing, Belgium, Company Share (%), 2008 Figure 78: Haematology, Belgium, Company Share (%), 2008 Figure 79: Histology And Cytology, Belgium, Company Share (%), 2008 Figure 80: Immuno Chemistry, Belgium, Company Share (%), 2008 Figure 81: Infectious Immunology, Belgium, Company Share (%), 2008 Figure 82: Microbiology Culture, Belgium, Company Share (%), 2008 Figure 83: Global Markets Direct Methodology

Companies Mentioned

- Ventana Medical Systems, Inc. - Sysmex Corporation - Siemens Healthcare - Qiagen N.V. - Phadia AB - Ortho-Clinical Diagnostics Inc. - Mindray Medical International Limited - Inverness Medical Innovations, Inc. - Hologic, Inc. - Gen-Probe Incorporated - F. Hoffmann-La Roche Ltd. - Digene Corporation - Dade Behring Holdings, Inc. - DiaSorin S.p.A - Bio-Rad Laboratories, Inc. - bioMerieux S.A. - Becton, Dickinson and Company - Beckman Coulter, Inc. - Abbott Laboratories